The role of molecular imaging in assessing degenerative parkinsonism – an updated review - Articles - Neurology · Psychiatry

RECOMMENDED

Parkinson’s Disease

Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review

Mov Disord.

Seppi K, Ray Chaudhuri K, Coelho M, Fox SH, Katzenschlager R, Perez Lloret S, Weintraub D, Sampaio C, and the collaborators of the Parkinson's Disease Update on Non-Motor Symptoms Study Group on behalf of the Movement Disorders Society Evidence-Based Medicine Committee

doi: 10.1002/mds.27602.

Progression marker of Parkinson’s disease: a 4-year multi-site imaging study

Brain Neurology Journ.

Burciu RG, Ofori E, Archer DB, Wu SS, Pasternak O, McFarland NR, Okun MS, Vaillancourt DE

doi: 10.1093/brain/awx146.

Further Publications NeurologyFurther Publications Psychiatry

Four-Dimensional Magnetic Resonance Imaging Assessment of Intracranial Aneurysms: A State-of-the-Art Review

Neurosurgery.

Castle-Kirszbaum M, Maingard J, Lim RP, Barras CD, Kok HK, Chandra RV, Chong W, Asadi H

doi: 10.1093/neuros/nyaa021.

Dementia

Molecular imaging in dementia: Past, present, and future

Alzheimers Dement.

Laforce R Jr, Soucy JP, Sellami L, Dallaire-Théroux C, Brunet F, Bergeron D, Miller BL, Ossenkoppele R

doi: 10.1016/j.jalz.2018.06.2855.

Parkinson’s Disease

Opicapone for the treatment of Parkinson's disease: A review of a new licensed medicine

Mov Disord.

Fabbri M, Ferreira JJ, Lees A, Stocchi F, Poewe W, Tolosa E, Rascol O

doi: 10.1002/mds.27475.

Aging and Cognitive FunctionsAnxiety and Depression

The impact of Tai Chi and Qigong mind-body exercises on motor and non-motor function and quality of life in Parkinson's disease: A systematic review and meta-analysis

Parkinsonism Relat Disord.

Song R, Grabowska W, Park M, Osypiuk K, Vergara-Diaz GP, Bonato P, Hausdorff JM, Fox M, Sudarsky LR, Macklin E, Wayne PM

doi: 10.1016/

Parkinson’s Disease

Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study

Lancet Neurol.

Wilson H, Dervenoulas G, Pagano G, Koros C, Yousaf T, Picillo M, Polychronis S, Simitsi A, Giordano B, Chappell Z, Corcoran B, Stamelou M, Gunn RN, Pellecchia MT, Rabiner EA, Barone P, Stefanis L, Politis M

doi: 10.1016/S1474-4422

Anxiety and Depression

The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease

Brain.

Maillet A, Krack P, Lhommée E, Météreau E, Klinger H, Favre E, Le Bars D, Schmitt E, Bichon A, Pelissier P, Fraix V, Castrioto A, Sgambato-Faure V, Broussolle E, Tremblay L, Thobois S

doi: 10.1093/brain/aww162

RECOMMENDED

Parkinson’s Disease

Compensation Strategies for Gait Impairments in Parkinson Disease: A Review

JAMA Neurol.

Nonnekes J, Ružicka E, Nieuwboer A, Hallett M, Fasano A, Bloem BR

doi: 10.1001/jamaneurol.

Related content

Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review

Progression marker of Parkinson’s disease: a 4-year multi-site imaging study

Four-Dimensional Magnetic Resonance Imaging Assessment of Intracranial Aneurysms: A State-of-the-Art Review

Molecular imaging in dementia: Past, present, and future

Opicapone for the treatment of Parkinson's disease: A review of a new licensed medicine

The impact of Tai Chi and Qigong mind-body exercises on motor and non-motor function and quality of life in Parkinson's disease: A systematic review and meta-analysis

Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study

The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease

Compensation Strategies for Gait Impairments in Parkinson Disease: A Review